These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3401892)

  • 21. [Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease].
    Mannebach H; Ohlmeier H; von Möllendorff E; Gleichmann U; Abshagen U
    Med Welt; 1981 Apr; 32(14A):517-20. PubMed ID: 7242311
    [No Abstract]   [Full Text] [Related]  

  • 22. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemodynamic effects of nitrate derivatives (trinitrine and isosorbide dinitrate)].
    Baligadoo S; Chiche P
    Coeur Med Interne; 1979; 18(2):271-82. PubMed ID: 114352
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The haemodynamic and anti-ischaemic effects of a single tablet of 80 mg isosorbide dinitrate in slow-release formulation and a review of nitrate tolerance.
    Silber S; Vogler AC; Krause KH; Theisen K
    Drugs; 1987; 33 Suppl 4():69-79. PubMed ID: 3622317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the haemodynamic effect of isosorbide-5-mononitrate and isosorbide dinitrate administered in intravenous injection to patients with acute myocardial infarction.
    Daskalov TR
    Cor Vasa; 1989; 31(5):376-86. PubMed ID: 2612170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemodynamic effect, effect duration and pharmacokinetics of 80 mg of isosorbide-5-mononitrate in acute myocardial infarct].
    Reifart N; Bussmann WD; Schirmer M; Kaltenbach M
    Med Welt; 1981 Apr; 32(14A):540-2. PubMed ID: 7242317
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of sublingual isosorbide dinitrate on hemodynamics in coronary patients with and without congestive heart failure (author's transl)].
    Wolf R; Beck OA; Habel F; Hochrein H
    Z Kardiol; 1977 Aug; 66(8):459-64. PubMed ID: 899150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.
    Wendt RL
    J Pharmacol Exp Ther; 1972 Mar; 180(3):732-42. PubMed ID: 4622308
    [No Abstract]   [Full Text] [Related]  

  • 30. [Development of tolerance to the hemodynamic effects of nitroglycerin].
    Schlup P; Zatti C; Studer H
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1927-30. PubMed ID: 6782669
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of isosorbide dinitrate on the blood circulation system in patients with ischemic heart disease].
    Gaponenko VA; Santova RA; Chilikina ON; Akhmetova MG; Moskalenko NP; Glezer GA
    Ross Med Zh; 1992; (4):45-7. PubMed ID: 1521022
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemodynamic effects of cutaneously administered isosorbide dinitrate ointment.
    Schinz A; Schnelle K; Klein G
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):297-301. PubMed ID: 669875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent effects of isosorbide-5-mononitrate on the venous, arterial and coronary arterial system of conscious dogs.
    Bassenge E; Strein K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Sep; 334(1):100-4. PubMed ID: 3785437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of nitroglycerin and isosorbiddinitrate on myocardial perfusion and hemodynamics in patients with and without coronary disease.
    Simon R; Amende I; Engel HJ; Lichtlen PR
    Scand J Clin Lab Invest Suppl; 1984; 173():47-58. PubMed ID: 6442002
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemodynamic effects of isosorbide-5-mononitrate at rest and during exertion in patients with serious angina pectoris].
    Biamino G; Oeff M; Andresen D; Lichey HJ; Prokein E; Arntz R; von Leitner E; Schröder R
    Med Welt; 1981 Apr; 32(14A):535-9. PubMed ID: 7242316
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
    Bödigheimer K; Nowak FG; Delius W
    Med Welt; 1981 Apr; 32(14A):543-7. PubMed ID: 7242318
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemodynamic effects of isosorbide dinitrate by intravenous infusion in subjects in hemodynamic equilibrium].
    Cappello C; Fusaro MT; Fontana PL; Gini M; Mattioli G
    Minerva Cardioangiol; 1988; 36(1-2):49-54. PubMed ID: 3386854
    [No Abstract]   [Full Text] [Related]  

  • 38. Infusions with molsidomine and isosorbide-5-mononitrate in congestive heart failure: mechanisms underlying attenuation of effects.
    Lehmann G; Hähnel I; Reiniger G; Lampen M; Beyerle A; Schömig A
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):212-20. PubMed ID: 9475262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Isosorbide mononitrate or dinitrate in coronary disease?].
    Schanzenbächer P; Kochsiek K
    Dtsch Med Wochenschr; 1983 May; 108(21):807-9. PubMed ID: 6851870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.